On 8 Oct 2026, CSPC PHARMA (01093.HK) unveiled Phase I data for SYS6002 in cervical cancer at IGCS 2026: confirmed ORR 35.9% and 28.6%; Phase III started.

On September 29, 2026, BIDU-W (09888.HK) weakened. As of 14:09, it quoted HK$84.40 per share, down 1.34%.

UBTECH ROBOTICS (09880.HK) fell 1.26% to HKD 78.050. The 5th Global Digital Trade Expo opened in Hangzhou; Tesla's CEO forecast 100 billion humanoid robots.

On September 22, 2026, RoboSense (02498.HK) edged slightly lower in the afternoon. At market close, it was quoted at HK$16.91, down 0.06%.

XIAOMI-W (01810.HK) rose 0.29% to HKD 27.660. Unitree launched the 22-DoF Dex5-S dexterous hand; GENISOM AI completed a B round.

On 21 September, SMIC (00981.HK) quoted HKD 64.900, down 0.38%. UMC signalled price rises, PSMC up to 40%; South Korea 1-20 September chip exports rose 259%.

This week's Going Global Weekly with mainland enterprises' Hong Kong listings and pharma globalisation forming the two main lines. On the financing side, TRANSSION, RED AVENUE NEW MATERIALS, ROBOTECHNIK and Junxin Environmental Protection passed the Hong Kong Stock Exchange listing hearing, CCTECH and SKYCHEM TECHNOLOGY advanced their H-share plans, Nazhen Technology launched its global offering with net fundraising of up to approximately HK$6.296 billion, and FORMS SYNTRON announced a delayed listing with refunds; on the pharma side, GENFLEET-B, LEADS BIOLABS-B and CSPC PHARMA released clinical data at WCLC, IMPACT THERAP-B received a positive opinion from CHMP, and GENSCRIPT BIO reached a wet laboratory services cooperation with the Lilly TuneLab platform.

On September 16, 2026, RoboSense (02498.HK) edged higher in the afternoon. As of 14:03, the stock was quoted at HK$16.16, up 1.32%.

on 16 September 2026, AI chip stocks strengthened, with SMIC (00981.HK) strengthening as well. As of 13:36, the company quoted HKD 63.200, up 4.03%.

On 15 September 2026, HENGRUI PHARMA (01276.HK) announced that its subsidiary Fujian Shengdi Pharmaceutical received a Drug Clinical Trial Approval Notice from the NMPA approving a clinical trial of HRS-4139 tablets in moderate-to-severe plaque psoriasis.

on 15 September 2026, humanoid robot stocks traded with volatility while MIDEA GROUP (00300.HK) strengthened. As of 13:47, the company quoted HKD 100.400, up 0.40%.

on 14 September 2026, humanoid robot stocks traded with volatility while XIAOMI-W (01810.HK) strengthened. As of 13:24, the company quoted HKD 27.020, up 2.50%.

on September 11, 2026, the AI chip theme saw a volatile pullback, with SMIC (00981.HK) weakening. As of 13:46, the company was quoted at HK$62.950, down 0.79%.

on September 10, 2026, the chip theme traded with volatility, with HUA HONG GRACE (01347.HK) moving higher. As of 13:55, the company was quoted at HK$113.900, up 2.06%.

On September 9, 2026, BIDU-W (09888.HK) traded firmly during the session. As of 13:39, it was quoted at HK$92.10, up 2.85%.

On September 8, 2026, RoboSense (02498.HK) traded weaker in the afternoon session. As of 15:27, it was quoted at HK$17.62, down 2.44%.